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The resistance of mosquitoes to chemical insecticides is
threatening vector control programmes worldwide. Cytochrome
P450 monooxygenases (CYPs) are known to play a major
role in insecticide resistance, allowing resistant insects to
metabolize insecticides at a higher rate. Among them, members
of the mosquito CYP6Z subfamily, like Aedes aegypti CYP6Z8
and its Anopheles gambiae orthologue CYP6Z2, have been
frequently associated with pyrethroid resistance. However, their
role in the pyrethroid degradation pathway remains unclear.
In the present study, we created a genetically modified yeast
strain overexpressing Ae. aegypti cytochrome P450 reductase
and CYP6Z8, thereby producing the first mosquito P450–
CPR (NADPH-cytochrome P450-reductase) complex in a yeast
recombinant system. The results of the present study show
that: (i) CYP6Z8 metabolizes PBAlc (3-phenoxybenzoic alcohol)
and PBAld (3-phenoxybenzaldehyde), common pyrethroid
metabolites produced by carboxylesterases, producing PBA (3-
phenoxybenzoic acid); (ii) CYP6Z8 transcription is induced by
PBAlc, PBAld and PBA; (iii) An. gambiae CYP6Z2 metabolizes
PBAlc and PBAld in the same way; (iv) PBA is the major metabol-
ite produced in vivo and is excreted without further modification;
and (v) in silico modelling of substrate–enzyme interactions
supports a similar role of other mosquito CYP6Zs in pyrethroid
degradation. By playing a pivotal role in the degradation of
pyrethroid insecticides, mosquito CYP6Zs thus represent good
targets for mosquito-resistance management strategies.
Key words: cytochrome P450 monooxygenase, insecticide, meta-
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INTRODUCTION
Mosquitoes transmit numerous parasites and viruses responsible
for severe human diseases, such as malaria or dengue. These
diseases represent an important burden in tropical and subtropical
regions, predominantly affecting developing countries [1].
Indeed, half of the world’s population is at risk of malaria, whereas
dengue represents a major threat in over 100 countries with more
than 2.5 billion people at risk [1].
In the absence of efficient treatments or vaccines, vector control
often represents the most effective means for limiting disease
transmission [2]. Effective vector control largely relies on the use
of insecticides targeting adults or larvae [3] and, because of their
high efficiency and cheapness, chemical insecticides remain the
first line of defence against mosquitoes when disease prevalence
is high. Chemical insecticides used for mosquito control belong
to various chemical families, from which pyrethroids are mainly
used for impregnating bednets and spraying.
However, resistance of mosquitoes to insecticides is threatening
vector control programmes worldwide [4]. Resistance can be
the consequence of a mutation of the protein targeted by the
insecticide (target-site resistance), a lower penetration or a
sequestration of the insecticide, or an increased biodegradation
of the insecticide (metabolic resistance) [5,6]. Detoxification
enzymes such as cytochrome P450 monooxygenases (P450s or
CYPs), GSTs and CCEs (carboxy/choline esterases) are known
for their roles in insecticide metabolism in insects [7,8] and their
overproduction has been frequently associated with resistance to
chemical insecticides in mosquitoes [5,6].
P450s are haem-thiolate-containing enzymes present in almost
all organisms and are involved in the metabolism of a wide
range of molecules [9]. Most P450s involved in detoxification
processes are expressed in the endoplasmic reticulum and catalyse
the oxidation of xenobiotics or endogenous compounds in the
presence of their obligatory electron donor CPR (NADPH-
cytochrome P450-reductase) and sometimes Cyt b5 (cytochrome
b5) [10]. Insect P450s are involved in metabolic resistance
to various insecticides [7,9,11,12]. In mosquitoes, P450s are
encoded by more than 100 CYP genes [13,14].
Following the development of transcriptomic tools in
mosquitoes [14,15], several P450s overtranscribed in pyrethroid-
resistant mosquitoes were identified [5,6]. Some of them have
been validated as pyrethroid metabolizers such as Anopheles
gambiae CYP6M2 and CYP6P3 [16,17], Anopheles funestus
CYP6P9b [18] and Aedes aegypti CYP9J32 [19]. Among
mosquito P450s, members of the CYP6Zs have been frequently
associated with pyrethroid resistance [15,20–22]; however, this
is not supported by functional studies as they do not appear to
metabolize pyrethroids. Chiu et al. [23] showed that An. gambiae
CYP6Z1 metabolized DDT, whereas pyrethroid metabolism was
not mentioned. McLaughlin et al. [24] revealed that An. gambiae
CYP6Z2 metabolized various substrates, but not pyrethroids. In
Ae. aegypti, CYP6Z8 was found to be induced by insecticides
and pollutants [22,25–28] and constitutively overtranscribed in
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pyrethroid-resistant populations [14,29]. This gene was also
found preferentially transcribed in tissues classically involved in
insecticide metabolism such as midgut and Malpighian tubules
[27].
In this context, the present study aimed at characterizing Ae.
aegypti CYP6Z8 substrate selectivity and its ability to metabolize
insecticides. For this purpose, a yeast expression system allowing
the co-expression of any mosquito microsomal P450 along
with its associated CPR was developed. Using this system,
we obtained a functional microsomal membrane complex of
CYP6Z8 and Ae. aegypti CPR, which was used for in vitro
metabolism assays. Our data indicate that although CYP6Z8
metabolizes various substrates, it is not capable of metabolizing
most insecticides. However, our data reveal that CYP6Z8 and
CYP6Z2, an anopheline orthologue of CYP6Z8, are likely to
play a pivotal role in the clearance of pyrethroid insecticides
via further catabolism of pyrethroid derivatives obtained by the
action of carboxylesterases. This is significant from an operational
vector control perspective as it is the first direct evidence that
secondary metabolism of insecticides pyrethroids by P450s is
linked to resistance. In silico 3D-modelling of substrate–enzyme
interactions supports the involvement of other mosquito CYP6Zs
in this process. The findings of the present study are discussed in
regard to metabolic resistance mechanisms and detoxification
pathways in mosquitoes.
EXPERIMENTAL
Materials, strains and media
Enzymes were purchased from New England Biolabs,
oligonucleotides were purchased from Eurogentec, chemicals
were purchased from Sigma–Aldrich and culture media were
purchased from Euromedex. DNA sequencing was performed by
Cogenics (Genome Express). Ae. aegypti mosquitoes from the
Bora-Bora strain were bred under standard insectary conditions as
described in Poupardin et al. [22]. Yeast Saccharomyces cerevisiae
strain W303-1B (MATα; leu2, his3, trp1, ade2-1, ura3, canR,
cyr+ ), henceforth known as W(N), represents the wild-type strain
used for the construction of all other strains described in the
present study and was kindly provided by Dr P. Urban and
Dr D. Pompon (University of Toulouse, INSA-UPS-LISBP).
SG(A)I synthetic minimum medium contained 20 g/l glucose
(SGI), 1 g/Ll bactocasamino acids, 6.7 g/l yeast nitrogen base
without amino acids and 40 mg/l DL-tryptophane. When required,
30 mg/l adenine was added (SGAI). N3 complete respiratory
medium consisted of 10 g/l yeast extract, 10 g/l bactopeptone and
2% glycerol. YPDA complete media contained 20 g/l glucose,
10 g/l yeast extract, 10 g/l bactopeptone and 30 mg/l adenine.
Repressive complete medium YPGE consisted of 5 g/l glucose,
10 g/l yeast extract, 10 g/l bactopeptone and 3% ethanol. Solid
media consisted of media described above with an addition of
20 g/l agar. All culture media were sterilized at 121 ◦C for 20 min
before use.
Cloning and heterologous expression of Ae. aegypti Cyt b5
The full cDNA sequence of Ae. aegypti Cyt b5 (VectorBase
accession number AAEL010017) was amplified by PCR using
high-fidelity Taq ExpandTM (Roche Applied Science) and the
following primers: forward, 5′-ATGTCGGAAGTGAAAACCT-
TCTCGC-3′, and reverse, 5′-GTTAGCAGGTTACTGAGTAA-
AGTAGAAC-3′. The amplification product was purified, cloned
and sequenced. BamHI and EcoRI restriction sites were inserted
by PCR using the following primers: forward, 5′-AAGGATCC-
AAAATGGCTGAAGTGAAAACC-3′ (start codon underlined),
and reverse, 5′-GCCGAATTCTTTACTGAGTAAAGTAGAAC-
C-3′. The fragment was purified, cloned into the pET22b
expression vector (Novagen) and resequenced. Protein expression
was performed in Escherichia coli Rosetta 2 (DE3) cells as
described previously [30]. Cyt b5 was then purified on a HiPrep
DEAE–Sepharose FF column (GE Healthcare) and eluted by
a step gradient of NaCl. The fraction containing the purified
Cyt b5 was then desalted using a HiPrep Desalting column
(GE Healthcare) and concentrated using an Amicon Ultra YM10
filter unit (Millipore). High-molecular-mass contaminants were
eliminated by using a HiLoad Superdex 75 column. Protein was
concentrated again and purity was checked by SDS/PAGE. The
Cyt b5 concentration was evaluated as described previously [31].
Cloning of CYP6Z8 and Ae. aegypti CPR for expression in yeast
The full cDNA sequence encoding Ae. aegypti CYP6Z8
(VectorBase accession number AAEL009131-RA) was amplified
by PCR using high-fidelity Taq ExpandTM (Roche Applied
Science) and the following primers: forward, 5′-GCAAAGAGTT-
CAAAATGGTCAT-3′, and reverse, 5′- GCACAAGTTCTCTA-
TTCAGC-3′ (start and stop codons underlined). A similar
procedure was used to amplify AeCPR (Ae. aegypti CPR;
VectorBase accession number AAEL003349-RA) using the
following primers: forward, 5′-ATGGACGCACAGACGGAAC-
3′, and reverse, 5′-TTTCAGCGGGAGATGGATTAAC-3′ (start
and stop codons underlined). Both amplicons were fully
sequenced and the corresponding synthetic gene was synthesized
by GeneCust with optimization for yeast expression (codon
usage, mRNA structure, GC content, and insertion of BamH1
and EcoRI sites at 5′ and 3′ ends respectively).
Construction of CYP6Z8 and CPR expression plasmids
CYP6Z8 and CPR synthetic genes were subcloned into yeast
replicative pYeDP60 and yeast integrative pYeDP110 plasmids
(kindly provided by Dr P. Urban) as described in Pompon et
al. [32]. Both vectors can be propagated in E. coli, hold an
expression cassette under a glucose-repressed and galactose-
inducible GAL10-CYC1 promoter and included an URA3 marker
(uracil auxotrophy complementation). The plasmid pYeDP60 also
contains an adenine ADE2 marker. Both plasmids were digested
with BamHI and EcoRI and purified with the Gel Extraction
Purification kit (Qiagen). CYP6Z8 and CPR synthetic genes were
ligated to pYeDP60 and pYeDP110 respectively using T4 DNA
ligase and the ligation product was used to transform DH5α
chemically competent E. coli. Positive colonies were detected
by PCR. Plasmids containing CYP6Z8 and CPR constructs were
purified, double-digested and sequenced. Expression plasmids
containing synthetic genes encoding CYP6Z8 and CPR were
called pYeDP60-6Z8 and pYeDP110-CPR.
Stable integration of AeCPR into the yeast genome
The W(AeR) strain was obtained by stable integration of the
AeCPR under the control of the GAL10-CYC1 promoter into
the W(N) genome. This genome integration was performed by
disrupting the yeast CPR gene. Briefly, pYeDP110-CPR was first
linearized by NotI and purified using a gel-extraction kit. Then,
W(N) yeast were transformed as described previously using the
lithium acetate/single-strand carrier DNA/PEG method [33] and
spread on SGAI-agar plates. Positive colonies were streaked
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individually on SGAI-agar plates, allowed to grow, and then
streaked again on N3-agar plates to ensure they can grow in
the absence of glucose (rho + phenotype). Positive colonies were
checked by PCR to ensure the integrity of the recombined genomic
locus.
Expression of CYP6Z8 in the W(AeR) yeast strain
W(AeR) yeast were transformed as described previously [33]
by pYeDP60-6Z8. Positive colonies were streaked on SGI-agar
plates and N3-agar plates and then checked by PCR to ensure
the presence of the CPR gene and pYeDP60-6Z8 plasmid.
Afterwards, 30 ml of stationary-phase SGI culture were used to
inoculate 500 ml of YPGE and the culture was allowed to grow
at 30 ◦C for 48 h. When a D600 of 4 was reached, 20 g/l galactose
was added to the culture to induce CPR and CYP6Z8 expression.
The culture was further allowed to grow at 30 ◦C for 7 h with
horizontal agitation at 140 rev./min before microsome extraction.
Preparation of yeast CYP6Z8 microsomes
The culture was first centrifuged at 2000 g for 18 min and the
pellet washed with 1 ml of TEK [50 mM Tris/HCl (pH 7.4),
1 mM EDTA and 100 mM KCl] per 0.5 g of cells. The pellet
was resuspended in 10 ml of TES [50 mM Tris/HCl (pH 7.4),
1 mM EDTA, 0.6 M sorbitol, 1 mM PMSF and 1 mM DTT] and
glass beads were added. Yeast cells were broken by vortex-mixing
five times for 30 s at 4 ◦C. TES (5 ml) was added to wash the
beads and the supernatant was transferred into a clean tube.
The beads were washed again twice, the supernatants pooled
and centrifuged at 10000 g for 10 min. The supernatant was
further ultracentrifuged at 27000 rev./min (rotor SW 28, Beckman
Coulter) for 1 h. The pelleted microsomes containing CYP6Z8
and CPR were resuspended in 500 μl of TEG [50 mM Tris/HCl
(pH 7.4), 1 mM EDTA and 30% glycerol] per 500 ml of yeast
culture, aliquoted and stored at − 80 ◦C until use [32].
Quantification of CPR and CYP6Z8 in yeast microsomes
Microsomal protein concentration was determined using the
Bradford method [34]. Specific content in P450s was measured
from the reduced carbon monoxide difference spectra according to
Omura and Sato [35] on both W(AeR)-CYP6Z8 microsomes and
W(AeR) microsomes. CPR activities were measured in W(AeR)-
CYP6Z8, W(AeR) and W(N) microsomes by following the
reduction of cytochrome c at 550 nm, in the presence of NADPH
[36].
Activity of CYP6Z8 microsomes against standard P450 substrates
Four resorufin ethers (methoxyresorufin, ethoxyresorufin,
pentoxyresorufin and benzyloxyresorufin; Sigma–Aldrich) were
tested as fluorogenic substrates against W(AeR)-CYP6Z8
microsomes. For each sample, 5 pmol of P450 in a total reaction
volume of 200 μl was added to 0.1 M phosphate buffer (pH 7.4)
containing 5 μM substrate, 0.1 mM NADPH and an electron
regeneration system (3 mM glucose 6-phosphate and 0.4 unit of
glucose-6-phosphate dehydrogenase), and incubated at 30 ◦C for
60 min. The production of resorufin was monitored by measuring
fluorescence at 537 nm excitation and 587 nm emission with a
Varioskan Flash Multimode Reader (Thermo Fisher Scientific). A
standard curve of resorufin (Sigma–Aldrich) was used to calculate
product formation rate. 7-Ethoxycoumarin O-de-ethylation was
monitored in a similar manner. The reaction mix was identical
as above, except that 8 pmol of P450 was used in a final volume
of 100 μl. After 10, 30 and 60 min, the reaction was stopped
by adding 100 μl of 50:50 (v/v) glycine/ethanol buffer and the
production of 7-OH (7-hydroxycoumarin) was quantified by
measuring the fluorescence at 380 nm excitation and 460 nm in
comparison with an 7-OH standard (Sigma–Aldrich). The effect
of the presence of Cyt b5 on CYP6Z8 activity was assessed by
supplementing the incubation reaction with 2.5–50 pmol of Cyt
b5. For the determination of kinetic parameters, the substrate
concentration ranged from 0 to 10 μM and the incubation time
was set to 15 min.
In vitro metabolism assays with non-fluorescent substrates
In vitro incubations contained 10 μM substrate, 50 pmol of Ae.
aegypti CYP6Z8 in W(aeR) microsomes or AgCYP6Z2 in E.
coli membranes [24] when indicated, 5 mM MgCl2, 0.1 mM
NADPH and the electron regenerative system (see above) for
a total reaction volume of 100 μl. Control experiments consisted
of omitting the NADPH regeneration system. After incubation at
30 ◦C, the reaction was stopped by adding 100 μl of acetonitrile,
shaking and incubation for 20 min and then centrifugation for
5 min at 16000 g to pellet microsomal proteins. The supernatant
was then transferred into ultraclean glass vials and analysed
by reverse-phase HPLC. The effect of the presence of Cyt b5
on CYP6Z8 activity was assessed by supplementing incubation
mixtures with 80 pmol (8 equivalents) of purified Ae. aegypti Cyt
b5.
Insecticide metabolism was monitored by reverse-phase HPLC
on an Agilent 1260 HPLC system equipped with a Nucleodur
C18 Polartec 250 mm×4.6 mm 3μ column (Macherey-Nagel) and
a multi-wavelength photodiode array. Insecticides and potential
metabolites were eluted with a gradient from 20 to 100%
acetonitrile in water containing 0.1% TFA (trifluoroacetic acid)
for 20 min, followed by a plateau at 100% for 4 min. For
imidacloprid, a gradient from 10 to 50% acetonitrile in 20 min
was used. Elution times of each compound and wavelengths used
for their detection are shown in Table 1.
MS identification of PBAlc (3-phenoxybenzoic alcohol) metabolites
The LC–MS/MS analysis was performed on an Agilent 1100
HPLC coupled to a Bruker Esquire 3000 + Ion Trap mass
spectrometer (Bruker Daltonics) in a positive mode (ESI + ) under
the following conditions: nebulizer gas 11 p.s.i. (N2), drying gas
8 l/min, drying temperature 350 ◦C, HV capillary 2000 V, HV End
Plate Offset − 500 V, capillary exit 103 V and skimmer 40 V.
In vivo metabolism assays
The ability of Ae. Aegypti third instar larvae to metabolize PBAlc
and excrete metabolites was assayed by exposing third-stage
larvae for 24 h to 10 μM PBAlc. In total, 25 larvae were exposed
to 250 μl of PBAlc (10 μM) in open microcentrifuge tubes
for 24 h under standard insectary conditions (26 ◦C, 14 h/10 h
light/dark period, 80% relative humidity). Controls consisted
of a PBAlc solution without larvae and a PBAlc solution with
larvae previously killed by heating at 95 ◦C for 10 min. After
24 h, reactions were flash-frozen in liquid nitrogen, thawed
and centrifuged at 13000 g for 1 min. Supernatant was then
transferred into HPLC vials containing an equal volume of
acetonitrile and subjected to HPLC analysis as described above
to quantify remaining PBAlc and excreted metabolites.
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Table 1 Metabolism of various xenobiotics by CYP6Z8
Turnover is measured as pmol of substrate depleted/min per pmol of P450. ND, not detected.
Substrate Type Turnover Elution time (min); (wavelength, nm)
PBALd Pyrethroid metabolite 1.978 +− 0.359 16.1 (232)
α-Naphtoflavone (αNF) Flavone 0.561 +− 0.022 19.1 (280)
Resveratrol Stilbene 0.463 +− 0.156 11.6 (300)
PBAlc Pyrethroid metabolite 0.425 +− 0.004 14.0 (232)
Diethylstilbestrol Stilbene 0.234 +− 0.072 18.3 (254)
Pyriproxifen Insecticide (growth regulator) 0.026 +− 0.001 18.7 (232)
Permethrin Insecticide (pyrethroid) ND 22.0 and 22.4 (232)
Deltamethrin Insecticide (pyrethroid) ND 21.4 (232)
PBA Pyrethroid metabolite ND 15.9 (232)
DDT Insecticide (organochlorine) ND 22.1 (232)
Temephos Insecticide (organophosphate) ND 19.4 (232)
Diflubenzuron Insecticide (chitin synthesis inhibitor) ND 16.7 (232)
Imidacloprid Insecticide (neonicotinoid) ND 13.2 (270)
Propoxur Insecticide (carbamate) ND 12.9 (232)
Induction of CYP6Z8 by hydrolysed pyrethroid metabolites
The induction of CYP6Z8 by PBAlc, PBAld (3-
phenoxybenzaldehyde) and PBA (3-phenoxybenzoic acid)
was investigated by exposing third stage larvae for 24 h to
25, 250 and 2500 nM of each compound and measuring the
CYP6Z8 transcription level by reverse transcription followed by
quantitative real-time PCR (RT-qPCR). Experimental procedures
used for RNA extractions, reverse transcription, real-time PCR
and primers used for qPCR are described in Poupardin et al.
[27]. Data analysis was performed according to the CT
method taking into account PCR efficiency [37] and using the
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Figure 1 Biochemical characterization of yeast W(AeR)-CYP6Z8 microsomes
(A) Fe2 + -CO compared with Fe2 + difference spectrum. The spectrum was obtained from 1 mg of microsomal proteins containing 494 pmol of P450. (B) CPR activity of W(AeR) microsomes. Activity
was quantified by monitoring the amount of reduced cytochrome c at 550 nm in the presence of NADPH and the NADPH regenerating system. (C) Michaelis–Menten plot of CYP6Z8–ethoxyresorufin
(ER) kinetic parameters.
housekeeping gene encoding the ribosomal protein L8 (AeRPL8,
GenBank® accession no DQ440262). Three independent
biological replicates using different egg batches were performed
and results were expressed as the mean transcription ratio relative
to controls (unexposed larvae). Transcription data were computed
by using a Mann–Whitney test on transcription ratios (n = 3).
Genes were considered significantly overtranscribed compared
with controls when the mean transcription ratio was superior to
1.5 and the Mann–Whitney P value was <0.05.
In silico substrate docking 3D modelling
The molecular models of CYP6Z8 and other CYP6Zs were
created based on the crystal structure of CYP3A4 ([38]; PDB
code 1TQN), currently the most homologous protein with a
known structure, with 28% identity. Docking studies were carried
out using GOLD v3.1 with the ChemScore scoring function
[39] and an active site radius of 20 Å (1 Å = 0.1 nm). Ligand
structures were obtained from ChemIDPlus (http://chem.sis.nlm.
nih.gov/chemidplus/). In total 50 binding modes were obtained
for deltamethrin, PBAlc, PBAld and PBA. Figures were prepared
using PyMOL (http://www.pymol.org).
RESULTS
CYP6Z8 sequence analysis
Ae. aegypti CYP6Z8 was cloned from cDNA (Bora-Bora strain)
and fully sequenced (CYP6Z8v1, GenBank® accession number
JQ970488). Sequence analysis revealed 49 nucleotide variations
compared with the genome sequence (gene AAEL009131,
Liverpool strain, AaegL1.2 genset) (Supplementary Figure S1 at
http://www.biochemj.org/bj/455/bj4550075add.htm). Of these,
13 were non-synonymous, leading to 97.14% identity with
AAEL009131-PA (Supplementary Figure S2 at http://www.
biochemj.org/bj/455/bj4550075add.htm). Only one non-
synonymous variation was located within SRS (substrate
recognition site) regions. This variation (C855A), leading to
the replacement of a phenylalanine by a leucine at position
285 is not likely to affect substrate-binding properties. Indeed,
structural models showed that this amino acid does not project
into the active site and does not affect its dimensions. In addition,
this variation was not predicted to affect the I helix position or
substrate access channels (results not shown).
Creating a yeast strain overexpressing mosquito CPR
The W(N) yeast strain was submitted to homologous
recombination with the integrative plasmid pYeDP110-CPR to
obtain the W(AeR) strain which overproduces AeCPR in the
presence of galactose (GAL promoter). PCR with specific primers
confirmed the stable replacement of the yeast CPR gene by the
insert containing the GAL promoter and AeCPR gene. Microsomes
extracted from galactose-induced W(AeR) cultures showed a
significant overexpression of CPR activity compared with the
W(N) strain (164 +− 49 nmol of reduced cytochrome c/min per
mg of protein compared with 32 +− 13 nmol/min per mg of
protein).
Co-expression of recombinant CYP6Z8 and CPR in yeast
An average of 17 mg/l W(AeR)-CYP6Z8 microsomal proteins
was obtained. The reduced CO-difference spectrum of W(AeR)-
CYP6Z8 microsomes had a characteristic maximum absorption
peak at 448 nm (Figure 1A). A minor peak was also observed
at 420 nm (incorrectly folded protein), which increased to
the detriment of the 450 nm peak for longer induction times,
suggesting that CYP6Z8 is moderately stable. The average P450
concentration was 195 +− 51 pmol/mg. Endogenous expression of
yeast P450s was not detectable in W(N) or W(AeR) microsomes.
Finally, the expression of AeCPR ranged from 97 to 209 nmol of
reduced cytochrome c/min (Figure 1B) and was not significantly
affected by the co-expression of CYP6Z8.
CYP6Z8 activity against standard P450 fluorescent substrates
W(AeR) microsomes expressing only AeCPR did not show
any significant activity against any P450 fluorescent substrate,
confirming the very low expression of endogenous yeast P450s
under these conditions. W(AeR)-CYP6Z8 microsomes were able
to metabolize fluorescent substrates at different rates (Table 2 and
Figure 1C). Determining apparent kinetic parameters, Km and
Vmax, for each fluorescent substrate showed that CYP6Z8 meta-
bolized preferentially ethoxyresorufin and benzyloxyresorufin
(kcat/Km ratios of 0.49 and 0.74 respectively), whereas pentoxyre-
sorufin and 7-ethoxycoumarin were metabolized at much lower
rates (kcat/Km ratios of 0.0094 and 0.17 respectively). Apparent
kinetic parameters for methoxyresorufin could not be determined
due to a non-Michaelian behaviour of this substrate. Although
Cyt b5 integration into W(AeR)-CYP6Z8 microsomes and its
interaction with the P450 were observed (results not shown),
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Table 2 CYP6Z8 specific activity against standard fluorescent P450 substrates
ND, not determined because of non Michaelis–Menten behaviour.
Substrate K m (μM) V max (nM/min) K cat (min− 1) K cat/K m
Benzyloxyresorufin 0.13 +− 0.02 2.41 +− 0.05 0.097 +− 0.002 0.74
Ethoxyresorufin 2.39 +− 0.28 30 +− 1 1.19 +− 0.05 0.49
7-Ethoxycoumarin 5.90 +− 0.90 49 +− 2 0.98 +− 0.04 0.17
Pentoxyresorufin 13.96 +− 3.14 3.29 +− 0.02 0.13 +− 0.01 0.0094
Methyloxyresorufin ND ND ND ND
supplementing the reaction with recombinant Cyt b5 did not lead
to a significant increase in activity for any of the substrates tested.
CYP6Z8 activity against insecticides and other xenobiotics
Metabolism of insecticides from various chemical classes
was assayed with W(AeR)-CYP6Z8 microsomes in the
presence or absence of NADPH and the NADPH regenerating
system. The degradation of the substrate and appearance
of metabolites were monitored by reverse-phase HPLC
(Table 1). The insecticides permethrin, deltamethrin, DDT,
temephos, diflubenzuron, imidacloprid and propoxur were
not significantly metabolized by CYP6Z8. However, CYP6Z8
metabolized different natural and synthetic xenobiotics such as
α-naphthoflavone, resveratrol, diethylstilbestrol and to a lesser
extent the insecticide pyriproxifen. As for fluorescent substrates,
the presence of Cyt b5 did not affect CYP6Z8 substrate specificity
and turnover (results not shown).
As pyrethroid catabolism may involve carboxylesterase-
mediated hydrolysis as a first step, the conversion of intermediate
metabolites, namely PBAlc and PBAld was also examined.
When PBAlc was used as a substrate (Figure 2A), no
significant metabolism occurred in the absence of NADPH
and the NADPH regenerating system. In the presence of
NADPH, PBAlc was metabolized by CYP6Z8 at a rate of
0.42 pmol/min per pmol of P450. PBAlc turnover was not
significantly affected by the presence of Cyt b5 (results not
shown). Several metabolites were produced by CYP6Z8 including
PBA [Rt (retention time) 15.8 min], PBAld (Rt 16 min) and
two more hydrophilic metabolites, M1 and M2 (Rt 11.1 min
and 12.6 min respectively). PBA accumulated gradually and was
the major metabolite after 60 min incubation, followed by the
M1 metabolite. PBAld never accumulated to a large extent; its
proportion increased progressively over 15 min before decreasing
for longer incubation times, suggesting the further conversion
of this metabolite. Finally, a minor M2 metabolite gradually
appeared during incubation. Kinetic parameters of PBAlc meta-
bolism were Km = 15.1 +− 2.9 μM, Vmax = 33.4 +− 1.5 pmol/min,
kcat = 0.66 +− 0.03 min− 1 and kcat/Km = 0.046.
When PBAld was used as a substrate (Figure 2B), a significant
conversion into PBAlc occurred in the absence of CYP6Z8,
suggesting that this reduction is CYP-independent. Conversion
into PBA strongly increased in the presence of CYP6Z8 and
Figure 2 Analysis of PBAlc and PBAld metabolism by CYP6Z8
HPLC chromatograms showing the time course of PBAlc (A) and PBAld (B) metabolism
by W(AeR)-CYP6Z8 microsomes. The lowest off-set corresponds to the negative control
( − NADPH) followed by reactions in the presence of NADPH stopped after 5, 15, 30 and
60 min. PBAlc, PBAld, PBA and metabolite peaks are indicated by arrows on the 60 min off-set.
NADPH (1.98 pmol/min per pmol of P450), confirming that
CYP6Z8 also metabolizes PBAld. PBAlc remained a significant
metabolite over time, indicating equilibrium between oxidation
and reduction reactions. As for PBAlc, a minor production of
M1 and M2 metabolites was noticed and PBAld turnover was
not significantly affected by the presence of Cyt b5 (results not
shown). Finally, no PBA metabolism occurred in the presence of
NADPH, indicating that this compound is not further metabolized
by CYP6Z8.
The ability of An. gambiae CYP6Z2, an anopheline ortho-
logue of CYP6Z8, to metabolize PBAlc and PBAld was also
investigated. These experiments performed with E. coli recom-
binant CYP6Z2 [24] under identical conditions demonstrated
the ability of CYP6Z2 to metabolize both PBAlc and PBAld,
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producing PBA together with minor M1 and M2 metabolites in
the same way as CYP6Z8 (Supplementary Figure S3 at http://
www.biochemj.org/bj/455/bj4550075add.htm).
Identification of metabolites
Positive-mode electrospray LC–MS detected PBAlc, PBAld,
PBA, M1 and M2 at 183, 199, 215, 200 and 228 m/z respectively.
PBAlc was detected 18 units below its theoretical mass (201
m/z), indicating its dehydration during LC-MS (Supplementary
Table S1 at http://www.biochemj.org/bj/455/bj4550075add.htm).
MS analyses did not allow the full identification of M1 and M2
metabolites. However, M1 and M2 metabolites did not appear
to result from the direct or sequential hydroxylation of PBAlc
or PBAld as no + 16 m/z were observed. In addition, LC–MS
m/z obtained for M1 and M2 did not match with any expected
metabolite structure.
MS/MS analyses by positive-mode electrospray fragmentation
detected various fragmentation ions associated with each
compound (Supplementary Table S2 at http://www.biochemj.org/
bj/455/bj4550075add.htm). The fragment shared by PBAld and
PBA (171 m/z) is likely to correspond to diphenylether. This
fragment could not be identified from M1 or M2, suggesting that
these two metabolites rather originate from PBAlc. In addition,
among all fragments, one was shared between PBAlc and M1 (155
m/z), suggesting a common backbone of these two compounds.
This fragment was not shared with M2. Moreover, replacing
H2O/0.1% TFA (pH 2.0) by 10 mM Tris buffer (pH 7.5) for
HPLC analysis resulted in the shift of PBA and PBAld peaks
(results not shown), whereas PBAlc, M1 and M2 peaks were not
affected (no change in signal intensity and Rt), suggesting that M1
and M2 do not possess any pH-dependent function, unlike PBAld
or PBA.
In silico 3D modelling of CYP6Z–substrate interactions
In order to better understand why pyrethroids and their metabolites
were metabolized or not by CYP6Zs, 3D models were built and
the docking modes of PBAlc, PBAld, PBA and deltamethrin were
predicted in silico. In CYP6Z8 and CYP6Z2, PBAld and PBAlc
bound in two alternative modes that allow metabolism either on
the phenyl or benzyl rings (Figure 3), consistent with experimental
findings showing two metabolites. Given the phenyl ring structure
of PBAld and PBAlc, interactions with aromatic side-chain amino
acids are of potential interest in substrate binding and metabolism.
A cluster of aromatic side chains are predicted in the active site of
CYP6Z8, Phe102, Phe110, Phe115, Tyr208 and Phe211, of which Phe115
and Tyr208 appear to be positioned as clamps above the haem
iron atom, thus potentially key residues in substrate positioning
for catalysis (Figure 3). Orientation in two binding modes is
predicted, consistent with the two products observed (PBAld
and PBA). Despite their lack of deltamethrin metabolism, both
CYP6Z8 and CYP6Z2 produced their highest binding scores
with this compound (∼42 kJ/mol) (Supplementary Table S3
at http://www.biochemj.org/bj/455/bj4550075add.htm). However
metabolism appears to be prevented in CYP6Z8 by internal
clashes with Tyr208, and in CYP6Z2 by residues close to the
haem (Leu365 and Phe115). Steric hindrance of PBA does not
appear to prevent metabolism since productive pose are predicted
in CYP6Z8. However, the low binding score points to a low
affinity for this molecule (Supplementary Table S3). Examination
of structural models of other Ae. aegypti and An. gambiae CYP6Zs
indicates they may all have the capacity to metabolize PBAlc and
PBAld and produce similar metabolites (Figure 4).
Figure 3 Predicted bindingmodes of PBAlc and PBAld in the CYP6Z8model
PBAlc (green) and PBAld (purple) binding are shown for the highest-ranked poses (A andB) and
lower-ranked poses (C and D). Residues that project into the active site are labelled. Superscript
text refers to amino acids belonging to SRS1 (1), FG loop (FG) and SRS5 (5) regions.
In vivo assays and regulation of CYP6Z8 expression by pyrethroid
metabolites
Incubating alive Ae. aegypti third instar larvae with PBAlc for 24 h
revealed a concomitant decrease in PBAlc in the growing medium
and an increase in PBA together with other minor metabolites,
suggesting that the PBA produced is directly excreted by larvae
without further modification (Figure 5).
In order to assess whether CYP6Z8 transcription is regulated
by its substrates and/or products, larvae were exposed for 24 h
to various concentrations of PBAlc, PBAld and PBA. The tran-
scription levels of CYP6Z8 compared with unexposed larvae were
then compared using qPCR (Supplementary Figure S4 at http://
www.biochemj.org/bj/455/bj4550075add.htm). CYP6Z8 tran-
scription was significantly induced by all compounds (2.0–3.4-
fold) with a moderate dose-dependent effect.
DISCUSSION
The present study aimed at co-expressing Ae. aegypti CYP6Z8
and AeCPR in an heterologous system, characterizing its activity
towards known P450 substrates and investigating its role in the
metabolism of insecticides.
CYP6Z8 sequence analysis revealed several variations in the
Bora-Bora strain compared with the genome sequence (Liverpool
strain, VectorBase AaegL1.2 genset). In total 49 nucleotides
variations, including 13 variations leading to amino acid changes,
were found, confirming the high polymorphism of mosquito
CYPs. These non-synonymous variations did not occur in the
conserved P450 signature motifs [12]. Only one amino acid
change occurred in an SRS at a position not strictly conserved
among CYP6Zs. As confirmed by 3D modelling, this replacement
(F285L) occurring in the oxygen-binding motif (SRS4) is likely
not to affect CYP6Z8 substrate specificity, as physicochemical
properties of these two amino acids are similar (Figure 4).
The yeast P450 expression system developed by Pompon et al.
[32] was chosen to create a novel genetically modified yeast strain
allowing the co-expression of any mosquito P450 together with
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Figure 4 Molecular models of CYP6Zs
Top panel: comparison of deltamethrin, PBAlc and PBAld docking in AeCYP6Z8 and AgCYP6Z2
(highest-ranked poses). Bottom panel: alignment of AeCYP6Z8 (green), AeCYP6Z9 (blue),
AeCYP6Z6 (purple), AgCYP6Z4 (yellow), AgCYP6Z3 (pink), AgCYP6Z1 (dark blue) and
AgCYP6Z2 (orange). The table shows a comparison of residues projecting into the active
site. Residues are labelled according to the position on CYP6Z8. Ae, Ae. aegypti; Ag, An.
gambiae.
its CPR. Such a system has been successfully used to express and
characterize various P450s from human, plants and fungi [32,40–
42]. The results of the present study show that replacing yeast
CPR by mosquito CPR under a galactose-inducible promoter
enables the W(AeR) strain to overexpress mosquito CPR at a high
level. Transforming the W(AeR) strain with an expression plasmid
carrying the CYP6Z8 gene under the same promoter allowed us to
produce a functional mosquito CPR–P450 membrane system. As
CPR is highly conserved in mosquitoes, this new tool should
allow the functional expression of any microsomal mosquito
P450. This was recently confirmed by the successful expression
of functional An. gambiae P450s using the W(AeR) yeast strain
(A. Chandor-Proust, M. Paine and J.-P. David, unpublished work).
To our knowledge, this is the first time a mosquito P450 has
been successfully expressed in yeast, along with its redox partner
and without protein sequence modification. Although E. coli is
commonly used to express P450s and has higher yields, some
eukaryote P450s are intractable for expression. The yeast system
thereby provides a useful alternative method with the advantage
Figure 5 In vivo metabolism of PBAlc
HPLC chromatograms showing excreted metabolites after exposing Ae. aegypti larvae alive or
dead for 24 h to 2 mg/l PBAlc. PBAlc and main metabolites are indicated by arrows.
of having eukaryotic cellular and redox machinery plus organelle
structure appropriate for the translation of eukaryotic P450s.
The results of the present study clearly indicate that our
recombinant CYP6Z8 is functional and able to metabolize
various standard P450 substrates. Kinetic data suggest that
benzyloxyresorufin is preferred, followed by ethoxyresorufin.
Supplementing reactions with purified Ae. aegypti Cyt b5 did
not affect CYP6Z8 substrate specificity and activity. Whether
CYP6Z8 does not strongly interact with Cyt b5 or the co-
expression of AeCPR and CYP6Z8 produces such a high
P450/CPR ratio making the presence of an extra electron donor,
such as Cyt b5, not necessary requires further investigation [43].
Then, the ability of CYP6Z8 to metabolize various
xenobiotics, including insecticides, was investigated. As for An.
gambiae CYP6Z2, CYP6Z8 did not metabolize permethrin and
deltamethrin [23,24]. In contrast with CYP6Z1, CYP6Z8 was
not capable of metabolizing DDT either. However, CYP6Z8
metabolized α-naphthoflavone and the stilbene resveratrol, as did
CYP6Z2 [24].
In mammals it has been demonstrated that pyrethroids can
be hydrolysed by carboxylesterases leading to the production
of PBAlc and PBAld and that these metabolites can be
further processed by P450s into PBA [44–46]. Recently,
in vitro metabolism assays with microsomes extracted from
Ae. aegypti larvae suggested that this detoxification pathway
occurs in mosquitoes [47]. Because CYP6Zs are frequently
overtranscribed in mosquito populations resistant and/or exposed
to pyrethroids, the ability of CYP6Z8 to metabolize common
pyrethroid metabolites was investigated further. Our results
clearly demonstrate that CYP6Z8 is capable of metabolizing
PBAlc into PBA, with PBAld being a transitory metabolite
(Figure 6). Similarly, we showed that its An. gambiae orthologue
CYP6Z2 can also metabolize PBAlc in the same manner,
supporting the functional orthology of these two mosquito P450s.
To our knowledge, CYP6Z8 and CYP6Z2 are the first insect
P450s shown to metabolize pyrethroid metabolites generated by
carboxylesterase hydrolysis.
Two minor more hydrophilic metabolites (M1 and M2) were
also detected. Examination of M1 and M2 metabolites by LC–
MS and MS/MS did not allow the absolute identification of their
chemical structure. The behaviour of PBAlc in positive-mode
electrospray was not trivial as the parental ions (183 m/z) did not
correspond to the theoretical mass (201 m/z), but suggested its
dehydration. Despite this, no direct additions of alcohol function
( + 16 m/z) were observed for M1 and M2, suggesting that
these compounds are not simply hydroxylated. Previous studies
have shown that the direct attack of pyrethroids by P450s often
produces 4′-hydroxylation in insects [17,48]. The results of the
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Figure 6 Proposed role of CYP6Z8 in pyrethroid metabolism
Broken arrows indicates a first attack by carboxylesterases [52]. Solid arrows indicate CYP6Z8
NADPH-dependent transformations. Arrow width is proportional to the initial reaction rate
of metabolite production. Hypothetical reactions forming the M2 metabolite are indicated
by question marks. In the generic representation of pyrethroids, X represents a halogenated
substituent and R is either a H (type I pyrethroid) or CN (type II pyrethroid) group.
present study suggest that the attack of pyrethroid metabolites
generated by esterase hydrolysis by CYP6Zs is different.
Because PBA is not metabolized by CYP6Z8, M1 and
M2 can only represent metabolites of PBAlc or PBAld.
Common fragmentation ions were found between M1 and PBAlc,
suggesting a similar backbone. In addition, M1 and M2 HPLC
Rt were not affected by pH variations as opposed to PBAld
and PBA, confirming that they do not carry acid or aldehyde
functions. Overall, these results support the hypothesis of M1
originating from PBAlc and M2 being a secondary metabolite
of M1 (Figure 6). Finally, in vivo experiments revealed that
PBA is the major metabolite produced and is excreted from
mosquitoes without further modification. In contrast, M1 and
M2 metabolites were not excreted from mosquitoes. Instead, two
more polar metabolites (M1′ and M2′ in Figure 5) separated by a
comparable Rt were observed, suggesting that M1 and M2 are
further processed before being excreted.
In silico 3D modelling of CYP6Z–substrate interactions
confirmed our experimental findings on CYP6Z8 and CYP6Z2
with good binding scores and limited clashes of pyrethroid
metabolites in the active site. Comparing 3D models between
various Aedes and Anopheles CYP6Zs supports the capacity of
other mosquito CYP6Zs to metabolize these and produce similar
metabolites (Figure 4). The inability of CYP6Z8 and CYP6Z2 to
metabolize deltamethrin was supported by 3D models showing
good binding scores but high clashes between active-site residues
and substrate or within substrate itself. Bulky residues in the FG
loop and SRS1 and SRS5 of mosquito CYP6Zs are probably
preventing the metabolism of large pyrethroids. Indeed, while
known pyrethroid metabolizers such as CYP6M2, CYP6B8 and
CYP3A1 may require aromatic residues in the active site at
position Phe115 to π-stack with the phenyl ring, and/or Phe102
to bind with the benzyl ring [17,49,50], the extensive network
of aromatic residues in the CYP6Z subfamily may restrict the
binding of the large pyrethroids, but stabilize the binding of
smaller compounds such as PBAlc or PBAld.
Overall, the results of the present study lift the veil on the pivotal
role of CYP6Z8 and CYP6Z2 in pyrethroid biodegradation in
mosquitoes and clarify why they have frequently been associated
with resistance [15,21,22,29,51], whereas their capacity to
metabolize pyrethroid insecticides could not be validated [23,24].
This is the first direct evidence that secondary metabolism of
insecticide pyrethroids by P450s is linked to resistance. Our
results strongly support the role of these P450s following the
action of carboxylesterases in order to clear mosquito body from
these metabolites. Although hydrolysed pyrethroid metabolites
such as PBAlc and PBAld are far less toxic than intact pyrethroids,
their accumulation is likely to be detrimental to mosquitoes.
Therefore the role of CYP6Zs in the mosquito response to
pyrethroids is not negligible and the over-transcription of these
genes in natural populations should be considered as supporting
evidence of metabolic resistance.
Genes encoding carboxylesterases have been frequently found
to be overtranscribed in pyrethroid-resistant populations and
their role in pyrethroid biodegradation has been established
in vitro [47]. However, to our knowledge, no particular
mosquito carboxylesterase has yet been validated as a pyrethroid
metabolizer. A better understanding of insecticide degradation
pathways in mosquitoes will allow for the pinpointing of
action points to develop new strategies to overcome resistance
mechanisms. In this frame, estimating the relative importance of
mosquito detoxification enzymes in resistance is also important,
but not trivial. Any enzyme involved in the insecticide degradation
pathway may have a different importance in the resistant
phenotype depending on its expression profile, the step catalysed,
its substrate specificity and turnover rate, and the toxicity
and lipophilicity of the metabolites produced. This certainly
represents the next research challenge for understanding how
mosquitoes adjust their metabolism to resist insecticides and
better manage these resistance mechanisms.
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Figure S1 Alignment of cloned CYP6Z8 cDNA compared with the genome
sequence
Coding sequence cloned from Bora-Bora strain cDNA was compared with the cDNA sequence
extracted from VectorBase (AaegL1.2 geneset, Liverpool strain). Differences are shaded.
Figure S2 Alignment of Ae. aegypti CYP6Z8 protein sequences
Differences between CYP6Z8 obtained from the genome sequence (AaegL1.2 geneset, Liverpool
strain) and CYP6Z8 cloned from the Bora-Bora strain are shaded. The degree of sequence
conservation is indicated by standard motifs. Substrate-binding site regions are indicated by
boxes.
Figure S3 Analysis of PBAlc metabolism by An. gambiae CYP6Z2
HPLC chromatograms (off-set) showing the time course of PBAlc metabolism by
AgCPR-CYP6Z2 membranes. The lowest off-set corresponds to the negative control ( − NADPH)
followed by reactions in the presence of NADPH stopped after 10 and 60 min. PBAlc, PBAld,
PBA and metabolite peaks are indicated.
1 To whom correspondence should be addressed (email jean-philippe.david@ujf-grenoble.fr).
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Figure S4 Induction of CYP6Z8 by PBAlc, PBAld and PBA
Third-stage larvae were exposed for 24 h to three increasing doses of each compound.
Transcription levels were measured by qPCR on pools of larvae from three independent replicates
and expressed as means +− S.E.M. relative to controls (unexposed larvae). The significance
of transcription ratios relative to controls were assessed by a Mann–Whitney test (n = 3).
*P < 0.05.
Table S1 LC–MS analysis of PBAlc and PBAld metabolites
Masses of [M + H]+ ions were measured by HPLC coupled with MS (electrospray positive
mode). Theoretical expected mass in this mode, dehydrated mass and observed mass are
indicated. -, no dehydration is observed; ?, whether dehydration occurs or not is unknown.
Compound Theoretical mass Dehydration ( − 18) Observed mass
PBAlc 201 183 183
PBAld 199 - 199
PBA 215 - 215
M1 Unknown ? 200
M2 Unknown ? 228
Table S2 MS/MS analysis of PBAlc and PBAld metabolites
Fragmentation ions observed in MS/MS (electrospray positive mode) are shown for each compound. Parental ions ([M + H]+ ) are shown in bold. Common fragments are underlined.
Compound Observed mass of fragmentation ions
PBAlc 183 165 155
PBAld 199 171
PBA 215 171
M1 200 182 172 155
M2 228 211 193 175 151
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Table S3 Docking binding scores
Binding scores of the best ranked poses (kJ/mol) of PBALc, PBAld, PBA and deltamethrin in
members of the CYP6Z family. Ae, Ae. aegypti; Ag, An. gambiae.
Family PBAlc PBAld PBA Deltamethrin
AgCYP6Z1 34.49 34.64 31.99 37.24
AgCYP6Z2 37.09 36.46 33.43 42.69
AgCYP6Z3 36.73 36.18 33.69 43.4
AgCYP6Z4 34.22 32.17 31.55 42.76
AeCYP6Z6 34.25 34.43 30.59 45.24
AeCYP6Z8_bora 37.63 35.71 32.28 42.93
AeCYP6Z8_liv 36.34 36.42 31.97 42.55
AeCYP6Z9 31.15 30.6 28.68 41.1
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